Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Open Source DNA: A New Way to Protect Privacy and Scientific Freedom in Genetic Research

By LabMedica International staff writers
Posted on 25 Sep 2009
Israeli and American scientists have devised a mathematical formula that can be used to protect genetic privacy while giving researchers much of the raw data they need to do pioneering medical research. More...


There exists a real fear spinning around today's genome research community that private genetic information could be used negatively against individuals. In 2008, after a published article found serious security holes in the way DNA data are made publicly available, health institutes in the United States and worldwide removed all genetic data from public access.

"Unfortunately, that knee-jerk response stymied potential breakthrough genetic research," says Dr. Eran Halperin of Tel Aviv University's Blavatnik School of Computer Sciences (Israel) and department of molecular microbiology and biotechnology. He wants to put this valuable DNA information back in circulation, and has developed the tool to do it-- safely.

Working with colleagues at the University of California in Berkeley (USA), Dr. Halperin devised the mathematical formula. Reported in the September 2009 issue of the journal Nature Genetics, the tool could keep millions of research dollars-worth of DNA information available to scientists. "We've developed a mathematical formula and a software solution that ensures that malicious eyes will have a very low chance to identify individuals in any study," commented Dr. Halperin, who is also affiliated with the International Computer Science Institute in Berkeley.

The mathematical formula that Dr. Halperin's team devised can determine which single nucleotide polymorphisms (SNPs, which are small pieces of DNA) that differ from individual to individual in the human population--are accessible to the public without revealing information about the participation of any individual in the study. Using computer software that implements the formula, the U.S. National Institutes of Health (NIH; Bethesda, MD, USA) and similar institutes worldwide can distribute important research data, but keep individual identities private. "We have been able to determine how much of the DNA information one can reveal without compromising a person's identity," said Dr. Halperin. "This means the substantial effort invested in collecting these data will not have been in vain."

Genome association studies can find links in the human genetic code for conditions such as autism and predispositions for cancer. Armed with this information, individuals can avoid environmental influences that might bring on disease, and scientists can develop new gene-based diagnosis and treatment tools.

Examining SNP positions in the genetic code, Dr. Halperin and his colleagues demonstrated the statistical improbabilities of identifying individuals even when their complete genetic sequence is known. "We showed that even when SNPs across the entire genome are collected from several thousand people, using our solution the ability to detect the presence of any given individual is extremely limited," he noted.

Dr. Halperin hopes his research will reverse the NIH policy, and he will provide access to the software so that researchers can use it to decide which genetic information can be safely loaded into a public database. He also hopes it will quash raging debates about DNA usage and privacy issues.

The Tel Aviv University-Berkeley research was conducted while Dr. Halperin was working with the International Computer Science Institute (ICSI), a nonprofit research institute with close relations to the University of California (UC) and Tel Aviv University.

Related Links:

Tel Aviv University's Blavatnik School of Computer Sciences
University of California in Berkeley
International Computer Science Institute



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.